This remarkable decrease in mean SCD1 and slightly lower DI18 in breast AT surrounding tumor 15 mm in size, may suggest that the signaling within the TME plays a role in breast tumor formation and that DI18 and SCD1 may contribute to accelerated cell proliferation that support the hypothesis [47] targeting SCD1 may provide a novel therapeutic strategy for cancer treatment. This evidence concerns the gene SCD and neoplasm.